Patent intelligence · US
US 12428379
Acylsulfonamide KAT6A inhibitors
Acylsulfonamide KAT6A inhibitors
Patent details — US 12428379
- Jurisdiction
- US
- Status
- granted
- Grant date
- Sep 30, 2025
- Expiration
- Sep 25, 2045
- Applicant
- Olema Pharmaceuticals, Inc.
- Claims
- 27
- CPC classes
- A61K, A61K31/415, A61K31/4155, A61K31/426
Quick answer
US 12428379 (Acylsulfonamide KAT6A inhibitors) is held by Olema Pharmaceuticals, Inc.. Status: granted. Granted Sep 30, 2025. Expires Sep 25, 2045 (19 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- Olema Pharmaceuticals, Inc.
- Grant date
- Expiration
- Claims
- 27
- CPC classes
- A61K, A61K31/415, A61K31/4155, A61K31/426, A61K31/436, A61K31/4439
More from Olema Pharmaceuticals, Inc.
Related pharmaceutical patents in our USPTO index.
-
US 12370181
Regimens of estrogen receptor antagonists
granted -
US 11672785
Tetrahydro-1H-pyrido [3,4-b]indole anti-estrogenic drugs
granted -
US 11229630
Tetrahydro-1H-pyrido [3,4-b]indole anti-estrogenic drugs
granted -
US 10624878
Tetrahydro-1H-pyrido [3,4-b]indole anti-estrogenic drugs
granted -
US 10292971
Tetrahydro-1H-pyrido[3,4-b]indole anti-estrogenic drugs
granted -
US 9018244
Benzopyran compounds, compositions and uses thereof
granted -
US 8071545
Therapies and compositions for controlling the stress mechanism and for stabilizing hemostasis in an organism
granted
Frequently asked questions
What is US patent 12428379?
US 12428379 (Acylsulfonamide KAT6A inhibitors) is held by Olema Pharmaceuticals, Inc.. Status: granted. Granted Sep 30, 2025. Expires Sep 25, 2045 (19 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 12428379?
Olema Pharmaceuticals, Inc. is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 8 pharmaceutical patents for this assignee.
When does US 12428379 expire?
Our index shows an expiration date of Sep 25, 2045 (19 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.